These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5162252)

  • 1. [Phenformin treatment of arteriosclerotic patients: changes induced in the plasma lipid picture. Preliminary note].
    Negri AU; Matteoli E; Zaini GF; Riva D
    Minerva Med; 1971 Nov; 62(89):4405-12. PubMed ID: 5162252
    [No Abstract]   [Full Text] [Related]  

  • 2. [The lipid reducing action of phenformin in primary type IV hyperlipoproteinaemia (author's transl)].
    Lang PD; Vollmar J; Klemens UH; von Löwis P; Gries FA; Koschinsky T; Huth K; Pilz E; Schlierf G; Kremer GJ; Lenhart P; Schwandt P; Hammerl H; Studlar M
    Dtsch Med Wochenschr; 1973 Nov; 98(48):2280-6. PubMed ID: 4762828
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of phenformin hydrochloride on serum cholesterol, triglycerides and body weight of nondiabetic hypercholesterolemic subjects.
    Burstein J; Jakobson T; Lindell KA; Nikiforow RE
    Ann Med Intern Fenn; 1968; 57(1):15-21. PubMed ID: 5726760
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic effect of pyridylcarbinolic ester of clofibric acid on the changes of the lipid and fibrinolytic picture in arteriosclerotic patients].
    Rugginenti
    Minerva Med; 1974 May; 65(35):1906-16. PubMed ID: 4601840
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood lipids and glucose tolerance in 100 patients with arteriosclerotic occlusions in the lower extremities].
    Beyrer K; May R; Sailer S
    Wien Klin Wochenschr; 1968 May; 80(20):392-4. PubMed ID: 5728030
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
    Vogelberg KH
    Dtsch Med Wochenschr; 1976 Dec; 101(51):1868-71. PubMed ID: 1001205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes induced by D-thyroxine treatment in blood lipid indices in arteriosclerotic subjects].
    Notarbartolo A; Di Fede G; Cupidi G; Rini GB
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):979-83. PubMed ID: 4463989
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenformin therapy of chemical diabetes.
    Danowski TS; Sunder JH; Stephan T; Nolan S; Ohlsen PM; Ahmad U; Vidalon C; Wingert JP
    J Clin Pharmacol; 1974; 14(11-12):638-50. PubMed ID: 4140199
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of long-term administration of clofibrate on the composition of blood lipids in patients with atherosclerosis.
    Poleszak J; Korolko A
    Pol Med J; 1972; 11(2):250-6. PubMed ID: 5071512
    [No Abstract]   [Full Text] [Related]  

  • 10. [A decrease in body weight, cholesterol and blood sugar under the influence of phenformin (phenylbiguanide) in patients with cancer and atherosclerosis].
    Dil'man VM; Riabov SI; Tsyrlina EV; Kirsanov AI; Kovaleva IG
    Vopr Onkol; 1972; 18(2):84-6. PubMed ID: 5012922
    [No Abstract]   [Full Text] [Related]  

  • 11. [Insulin secretion and hydrocarbon tolerance in essential obesity in women (influence of fenfluramine, phenformin and D-amphetamine)].
    Cabezas Cerrato J; Catalán E; Vila T; Fernández-Cruz A
    Rev Clin Esp; 1973 May; 129(4):337-42. PubMed ID: 4720279
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of long-term therapy with phenformin plus metanabol on blood fibrinolytic activity, platelet adhesiveness and lipid metabolism in patients with arteriosclerosis.
    Perzanowski A; Bielawiec M; Myśliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):381-8. PubMed ID: 63425
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study on the relationship between changes of blood lipids and the fibrinolytic picture in ambulatory patients with arteriosclerosis].
    Rugginenti A
    Minerva Med; 1974 May; 65(34):1873-7. PubMed ID: 4842771
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of Clofibrat on plasma lipid levels.
    Szostak WB; Cybulska B; Ruzyllo E
    Mater Med Pol; 1971; 3(4):12-4. PubMed ID: 5162168
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenformin effect on body weight, lipids and glucose regulation.
    Alterman SL
    Pol Arch Med Wewn; 1969; 42(3):291-7. PubMed ID: 5790046
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic abnormalities in premature coronary disease: effects of therapy.
    Tzagournis M; Seidensticker JF; Hamwi GJ
    Ann N Y Acad Sci; 1968 Mar; 148(3):945-57. PubMed ID: 4872315
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenformin effect on body weight, lipids, and glucose regulation.
    Alterman SL; Lopez-Gomez AA
    Ann N Y Acad Sci; 1968 Mar; 148(3):884-91. PubMed ID: 4872312
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes of the blood lipid pattern in diabetics under treatment with chlorpropamide and phenethyl-1-biguanide].
    Meduri D; Polito R
    Minerva Med; 1969 Jun; 60(49):2439-48. PubMed ID: 5802656
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of the antilipidogenic and hypolipidemic effects of Insoal in diabetics and atherosclerotics].
    Warembourg H; Jaillard J
    Lille Med; 1967 May; 12(4):Suppl:510-5. PubMed ID: 5619704
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetes mellitus and obesity: phenformin hydrochloride as a research tool.
    Danowski TS
    Metabolism; 1967 Sep; 16(9):865-9. PubMed ID: 4860366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.